-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SBP-0069330 in Smoking Cessation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SBP-0069330 in Smoking Cessation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SBP-0069330 in Smoking Cessation Drug Details: SBP-0069330 is under development for the...
-
Product Insights
NewNet Present Value Model: Panbela Therapeutics Inc’s SBP-101
Empower your strategies with our Net Present Value Model: Panbela Therapeutics Inc's SBP-101 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SBP-0069330 in Substance (Drug) Abuse
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.SBP-0069330 in Substance (Drug) Abuse Drug Details:SBP-0069330 is under development for the treatment of substance abuse...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – UBX-1325 in Diabetic Macular Edema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - UBX-1325 in Diabetic Macular Edema report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. UBX-1325 in Diabetic Macular Edema Drug Details: UBX-1325 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TransCon IL-2 Beta/Gamma in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TransCon IL-2 Beta/Gamma in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TransCon IL-2 Beta/Gamma in Metastatic Colorectal Cancer Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Iptacopan Hydrochloride in Acquired (Autoimmune) Hemolytic Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Iptacopan Hydrochloride in Acquired (Autoimmune) Hemolytic Anemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Iptacopan Hydrochloride in Acquired (Autoimmune) Hemolytic Anemia Drug...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ivospemin Hydrochloride in Pancreatic Ductal Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ivospemin Hydrochloride in Pancreatic Ductal Adenocarcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ivospemin Hydrochloride in Pancreatic Ductal Adenocarcinoma Drug Details: Ivospemin hydrochloride...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABSK-021 in Small-Cell Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ABSK-021 in Small-Cell Lung Cancer Drug Details: ABSK-021 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AlloStemspine in Low Back Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AlloStemspine in Low Back Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AlloStemspine in Low Back Pain Drug Details: The therapeutic candidate is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Hymecromone in Pulmonary Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Hymecromone in Pulmonary Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Hymecromone in Pulmonary Hypertension Drug Details:Hymecromone is under development for the treatment of...